Cargando…
Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis
Atorvastatin δ-lactone, a major, pharmacologically inactive metabolite, has been associated with toxicity. In a previous study we showed that polymorphisms of UGT1A3 influence atorvastatin δ-lactone formation. Here we investigated the reverse reaction, atorvastatin δ-lactone hydrolysis, in a human l...
Autores principales: | Riedmaier, Stephan, Klein, Kathrin, Winter, Stefan, Hofmann, Ute, Schwab, Matthias, Zanger, Ulrich M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147178/ https://www.ncbi.nlm.nih.gov/pubmed/21852972 http://dx.doi.org/10.3389/fphar.2011.00041 |
Ejemplares similares
-
Paraoxonases (PON) 1, 2, and 3 Polymorphisms and PON-1 Activities in Patients with Sickle Cell Disease
por: Reichert, Cadiele Oliana, et al.
Publicado: (2019) -
Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
por: Mackness, Bharti, et al.
Publicado: (2013) -
Alzheimer’s Disease and Paraoxonase 1 (PON1) Gene Polymorphisms
por: Saeidi, Mohsen, et al.
Publicado: (2017) -
Effects of Intronic and Exonic Polymorphisms of Paraoxonase 1 (PON1) Gene on Serum PON1 Activity in a Korean Population
por: Eom, Sang-Yong, et al.
Publicado: (2011) -
Serum paraoxonase 1 (PON1) measurement: an update
por: Ceron, Jose J, et al.
Publicado: (2014)